Clinical Trials Directory

Trials / Completed

CompletedNCT04526808

Effects of Low FODMAP Diet on Leaky Gut

Effects of Low FODMAP Diet on Leaky Gut and Mucosal Immune Cell Abundance in Diarrhea-predominant Irritable Bowel Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The pathophysiology of Irritable bowel syndrome (IBS) is multifactorial involving complex interplay of altered intestinal permeability, mucosal immune activation, visceral hypersensitivity and gut dysbiosis. Although the exact triggers for these pathological changes in IBS are not clear but diet might play an important role. In fact, several studies have reported improvement in gastrointestinal symptoms on a diet low in FODMAPs (LFD) in patients with IBS, specifically in diarrhea predominant IBS (IBS-D). However, the mechanism of action of LFD is not well understood.

Detailed description

we aim to evaluate the following in patients with IBS-D. The effect of LFD on colonic permeability. 2.The effect of LFD on abundance of colonic mucosal immune cells specifically T-cell and mast cell abundance 3.The effect of LFD on colonic mucosal microbiome

Conditions

Interventions

TypeNameDescription
OTHERFODMAP dietlow FODMAP diet

Timeline

Start date
2019-05-20
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2020-08-26
Last updated
2025-05-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04526808. Inclusion in this directory is not an endorsement.

Effects of Low FODMAP Diet on Leaky Gut (NCT04526808) · Clinical Trials Directory